-
The impact of FDA’s social media guidance for pharmaceutical companies
Pamela Lewis Dolan PharmaceuticalThe Food and Drug Administration took a significant step forward in clarifying the responsibilities pharmaceutical companies have concerning social media activity in the recent release of a draft guidance document. But, as uncertainties still remain, the impact this guidance will have on pharmaceutical companies embracing this new venue of communication is unclear.
-
Stage 2 meaningful use readiness a growing concern
Pamela Lewis Dolan Healthcare AdministrationA survey recently released by the Centers for Disease Control and Prevention found there has been tremendous growth in electronic health record use in the U.S. over the past several years, thanks in part to the meaningful use incentive program. But there may be a speed bump in the road to a connected healthcare system as the meaningful use program enters its second stage.
-
Drug information education for practicing physicians: Part II
Mike Wokasch PharmaceuticalAs mentioned in my previous post, the recent announcement that GlaxoSmithKline would no longer pay physicians to do educational or promotional speaking about disease and prescription drugs got me thinking about the state of physician education, especially as it pertains to drug information. We talked about eliminating the potential for drug company bias and influence on physician prescribing practice by essentially "cleansing" the drug information development process of any financial support from drug companies.
-
Have a heart: A pharmacist’s reflection on medicine adherence
Jason Poquette PharmaceuticalWe know that compliance with prescribed medication therapies is embarrassingly low. So have a heart and teach your patients how to take their prescription medication. It's more important than you might think. In fact, results from a recent study suggest that greater adherence to prescribed therapies following an MI (myocardial infarction) significantly improve results and reduce readmissions to the hospital.
-
How to navigate the politics of medicine
Karen Childress Healthcare AdministrationThere are plenty of doctors who willingly — even excitedly — take on leadership roles that land them squarely in the middle of all kinds of interesting and challenging encounters within an organization. Thank goodness for them, because someone needs to be on the front line advocating for patients and members of the medical staff.
-
New contractor for insurance exchange website faces quite a challenge
Pamela Lewis Dolan Healthcare AdministrationAfter its three-year contract to build the federal health insurance exchange website culminated in a launch full of glitches and bad press, CGI Federal did not receive a contract renewal. Instead, the federal government is putting its faith — and more than $45 million — in Arlington, Va.-based Accenture Federal Services to oversee the HealthCare.gov website.
-
Drug information education for practicing physicians: Part I
Mike Wokasch PharmaceuticalThe recent announcement that GlaxoSmithKline would no longer pay physicians to do educational or promotional speaking about disease and prescription drugs got me thinking about the state of physician education, especially as it pertains to drug information for physicians.
-
Health spending growth low for 4th consecutive year
Pamela Lewis Dolan Healthcare AdministrationFor the fourth consecutive year, growth in healthcare spending remained historically low. But the likelihood this trend will continue, and how the Affordable Care Act will impact it, is still in question. From 2009 to 2012, the U.S. saw the slowest growth in healthcare spending since the government started tracking these trends in the 1960s, according to data released by the Centers for Medicare and Medicaid Services.
-
New advances in the hydrophilicity of carotenoids
Dr. Afsaneh Motamed-Khorasani PharmaceuticalCarotenoids have antioxidant properties and are mostly hydrophobic in nature. In recent years, attempts have been made to increase the hydrophilicity of carotenoids due to their potential applications in the medicine and food industries.
-
Pharmacists ranked No. 2 in honesty/ethics, but ...
Jason Poquette PharmaceuticalMuch talk has been generated recently among the members of the pharmacist profession about the No. 2 ranking we achieved in honesty/ethics in the latest Gallup poll. This is a significant achievement, as the poll spans a broad range of professions both inside and outside the boundaries of healthcare and medicine. On the other hand, there is a somewhat "untold" story to this Gallup poll data.
All Pharmaceutical Articles